Literature DB >> 21560725

Implementation of therapeutic hypothermia after cardiac arrest--a telephone survey of Connecticut hospitals.

Karol Kremens1, Andrew Seevaratnam, Jonathan Fine, Dorothy B Wakefield, Lewis Berman.   

Abstract

RATIONALE: We hypothesize that despite excellent evidence supporting use of therapeutic hypothermia (TH) after cardiac arrest, only some of Connecticut hospitals utilize this technique for cardiac arrest patients.
METHODS: Telephone survey of all adult acute care Connecticut hospitals between January and April 2010.
RESULTS: Among 31 adult acute care hospitals, 27 care for cardiac arrest patients. Seventeen out of 27 hospitals use TH (63%) for cardiac arrest patients. No significant association was found between use of TH and hospital size (P=0.14), ICU type (P=0.07) or BC/BE critical-care physician staffing (P= 0.22). Lack of resources and cost of TH were commonly mentioned as barriers.
CONCLUSIONS: Therapeutic hypothermia is underutilized in Connecticut with almost half of all hospitals currently not employing TH. Given the slow adoption rate of TH, state-level leadership may be indicated to accelerate implementation of this life-saving technique.

Entities:  

Mesh:

Year:  2011        PMID: 21560725

Source DB:  PubMed          Journal:  Conn Med        ISSN: 0010-6178


  2 in total

1.  Therapeutic hypothermia after out-of-hospital cardiac arrest in Finnish intensive care units: the FINNRESUSCI study.

Authors:  Jukka Vaahersalo; Pamela Hiltunen; Marjaana Tiainen; Tuomas Oksanen; Kirsi-Maija Kaukonen; Jouni Kurola; Esko Ruokonen; Jyrki Tenhunen; Tero Ala-Kokko; Vesa Lund; Matti Reinikainen; Outi Kiviniemi; Tom Silfvast; Markku Kuisma; Tero Varpula; Ville Pettilä
Journal:  Intensive Care Med       Date:  2013-02-16       Impact factor: 17.440

Review 2.  Clinical applications of targeted temperature management.

Authors:  Sarah M Perman; Munish Goyal; Robert W Neumar; Alexis A Topjian; David F Gaieski
Journal:  Chest       Date:  2014-02       Impact factor: 9.410

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.